BCG failure Thermotherapy/Synergo
{"Image DocumentName": "BCG failure Thermotherapy/Synergo", "Image ImageDescription": "80mg MMC: TC weekly x6-8 weeks ,maintenance x4-6 sessions every 6-8 weeks. In a recent systematic review : TC 59% relative reduction in NMIBC recurrence. compared with MMC alone, with a bladder preservation rate of 87.6%, Lammers RJM, et al. Eur Urol 2011;60:81\u201393. UK bladder cancer trial (HYMN, ClinicalTrials.gov identifier NCT ) Phase 3 trial : TC +MMC vs. 2nd course of BCG in NMIBC with BCG failure.", "Image XResolution": "37", "Image YResolution": "37", "Image ResolutionUnit": "Pixels/Centimeter", "Image Software": "SlidePlayer", "Image YCbCrPositioning": "Centered"}